2xumuDCGal1short plasmid from Nathan Hillson

Sequence by GenScript Sequence by Depositor

2xumuDCGal1short

Cat. No.:

MC_0009852

Availability:

4 µg of lyophilized plasmid
(1 µg for low-copy plasmid)

Price:

$65

Edit in GenSmart Design

General

Specification

Comments (0)

Keywords	Expression
Vector Backbone
Source	Member Deposit
Depositor	Nathan Hillson
Organization	The Joint BioEnergy Institute (JBEI) - CA
Description	pRS426yeGFP derivative plasmid
Publication	Dossani et al. (2017) A combinatorial approach to a suite of Synthetic Transcriptional Factor-Promoter pairs for yeast metabolic engineering.

Plasmid Copy	High Copy
Bacterial Resistance	Ampicillin
Growth Strain	TOP10
Growth Temperature	37°C
Plasmid Size (bp)	6728

*This material may be covered by one or more patents, trademarks and/or copy rights owned or controlled by Depositors or any third parties. This material is available to academic and nonprofit organizations for research use only. Please contact MolecularCloud at plasmid@genscript.com and the Depositor directly if you are from industrial institute or attempt for profit application. This material is not intended to be used therapeutic or diagnostic purposed in humans or animals.

Customers who viewed this item also viewed:

pRed_Cas9_recA_∆poxb300

CRISPR

pTargetF

CRISPR

pUC57-2019-nCoV-PC:RdRP

This plasmid contains part of 2019-nCoV(SARS-CoV-2) RdRP gene and can be used as positive control for the detection of 2019-nCoV(SARS-CoV-2) by qRT-PCR

pcDNA3.1+/C-(K)DYK-ACE2 (NM_021804.2, OHu20260)

Homo sapiens angiotensin I converting enzyme 2 (ACE2), the receptor for 2019-nCoV(SARS-CoV-2).

2019-nCov_pcDNA3.1(+)-P2A-eGFP

The plasmid is used for 2019-nCoV(SARS-CoV-2) surface glycoprotein expression (Codon Optimized for Mouse expression system). The surface glycoprotein is integrated with eGFP protein through P2A, which can be used for flow cytometry antibody screening or immunological research.